GSK to pay $1 billion to acquire exclusive rights for J&J hepatitis B therapy
HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights.
Drugs
Health
Pharma
Drugs
Health
Pharma
J&J halts final phase of trials of a drug to treat hypertension, says “futile”
HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to.
Drugs
Pharma
Johnson & Johnson pulls out of HIV phase III trial
Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.
Medical
Hetero buys J&J’s manufacturing site in India
HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private.